What is Regenxbio's total revenue?

Regenxbio (RGNX) reported total revenue of $6.39M in Q1 2026.

How has Regenxbio's total revenue changed year-over-year?

Regenxbio's total revenue decreased by 92.8% year-over-year, from $89.01M to $6.39M.

What is the long-term trend for Regenxbio's total revenue?

Over 4 years (2021 to 2025), Regenxbio's total revenue has grown at a -22.4% compound annual growth rate (CAGR), from $470.35M to $170.44M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Regenxbio RGNX Total Revenue

Total Revenue at other companies

Regeneron PharmaceuticalsREGN

$3.61B+19.0%

Sarepta Therapeutics, Inc.SRPT

$730.8M-1.9%

BiogenBIIB

$2.48B+1.9%

BioMarin PharmaceuticalsBMRN

$766.21M+2.8%

EyePoint, Inc. EYPT

$696K-97.2%

Ultragenyx PharmaceuticalRARE

$136M-2.2%

Segments

By product

See full

Zolgensma And Itvisma Royalties$5.05M-70.3%

Total Service Revenue$1.3M-33.6%

Nippon Shinyaku Services$1.01M-43.0%

Other Service Revenue$292K+54.5%

Other financials

Income statement

See full

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's total revenue?: Regenxbio (RGNX) reported total revenue of $6.39M in Q1 2026.
How has Regenxbio's total revenue changed year-over-year?: Regenxbio's total revenue decreased by 92.8% year-over-year, from $89.01M to $6.39M.
What is the long-term trend for Regenxbio's total revenue?: Over 4 years (2021 to 2025), Regenxbio's total revenue has grown at a -22.4% compound annual growth rate (CAGR), from $470.35M to $170.44M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.